Germany Considers Tighter Investment Rules Amid Nord Stream 2 Rumors
The German government is examining measures that could help it stop a potential sale of the Nord Stream 2 pipeline after speculation emerged earlier this year over reviving pipeline gas deliveries from Russia.
Berlin is considering amending the legal basis for investment screening, the economy ministry said in response to a parliamentary inquiry from Green party lawmakers including Michael Kellner, which was first reported by Der Spiegel magazine on Friday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Monaco hold talks with Barcelona's Marc-André ter Stegen
AS Monaco have held talks with Barcelona's Marc-André ter Stegen (33) regarding a move, according to a report from L'Équipe. The Principality club have cast their net far and wide this summer in their search for a new No.1. Monaco's CEO, Thiago Scuro, confirmed upon the conclusion of the Ligue 1 season that a new goalkeeper was sought after after the current options, Radoslaw Majecki and Philipp Köhn, failed to convince over the duration of the campaign. Advertisement David De Gea was considered before he renewed at Fiorentina. Djordje Petrovic and Marcin Bulka have also been linked with Monaco, as have Torino's Vanja Milinkovic-Savic and Trabzonspor's Ugurcan Çakir. The latter represents a more feasible option, financially. Ter Stegen, who has recently seen stiff competition arrive at Barcelona in the form of Joan Garcia, is an option. L'Équipe even understands that talks were recently held with the German international, whose contract with the Catalan club runs until 2028. GFFN | Luke Entwistle
Yahoo
an hour ago
- Yahoo
Budapest Pride: Unprecedented crowd defies Hungarian government at 'illegal' march
Well over a hundred thousand people marched in the Budapest Pride march organised by the NGO Rainbow Mission and city hall, despite the government's ban, standing up for the rights of the LGBTQ+ community as well as for freedom of assembly, and against the Hungarian government's policies. In the spring, the Hungarian ruling parties attempted to ban the annual regular human rights march of the LGBTQ community through a series of constitutional and legislative amendments on the grounds that it violates the rights of children, which they have put above other fundamental rights by amending the constitution. The police rejected the application for a permit by the NGOs that usually organise Pride in the past, at which time the Mayor of Budapest, Gergely Karácsony, announced that another event, the Budapest Pride march, would be held as a municipal event, because the municipality is not subject to the law on assembly and therefore, according to their interpretation of the law, does not need to apply for a permit to hold the event. The police called the event illegal and warned that participants could face fines and organisers up to one year in prison. Despite this, a huge crowd turned out. "I feel we have to stand up now, if we don't speak out now we may never have the chance to do so again," one participant told Euronews. "We're not that political, we really just want to be free, and this is how we can be free, by coming out and standing up for ourselves," a young couple told us. There was concern before the event that police had allowed counter-demonstrations by several far-right groups on the route of the march, but in the event, they were separated from the Pride march and their presence did not cause any disruption. Although the Our Homeland counter-demonstrators blocked the Freedom Bridge on the original route of the march, they were surrounded by police on both sides while Pride participants crossed the Elisabeth Bridge. "What is happening here is completely illegal, it is endangering the healthy development of children, and I find it very sad that the police are not stopping this process," Tamás Gaudi-Nagy, executive director of the National Legal Defence Service, told Euronews. "While the national radical organisations have been restricted in their demonstrations, as they have been for many years, the protesters of Our Homeland have not been allowed to cross the Liberty Bridge." The march was joined by more than 70 members of the European Parliament and several mayors from various European capitals. One of the organisers of the event, Budapest Mayor Gergely Karácsony, who has been threatened with jail by the Hungarian government's justice minister, said in his speech: "If you can ban a Pride event in a European Union member state, then no mayor in Europe is safe, and today, by so many of you coming, you have made Budapest the capital of Europe for this day." Karácsony said that the participants "showed a big gesture to the powers that be", while at the same time he also took a swipe at Péter Magyar, the leader of the strongest opposition party, Tisza, who did not participate in the march and only cautiously posted a message of support on social media without mentioning the name of the event. The mayor said that they would not vote for just anyone in the election against the powers that be. They will support whoever they can rightly expect to make Hungary their common home again. According to the police, to whom Karácsony nevertheless gave special thanks, they had a lot of trouble with what they thought was an illegal gathering, and blamed the organisers for not co-operating with them. However, by 20:00, a total of only 36 people had been stopped and only two people had been arrested - one for hooliganism and one for possession of drugs - meaning that Budapest Pride ended with literally no major incidents.
Yahoo
an hour ago
- Yahoo
Johnson & Johnson's (JNJ) IMAAVY Demonstrates Superior gMG Control
Johnson & Johnson (NYSE:JNJ) is one of the 12 stocks that will make you rich in 10 years. On June 23, J&J announced new data from an indirect treatment comparison (ITC) study. The data show that the company's drug, IMAAVY (nipocalimab-aahu), demonstrated consistent and sustained disease control in patients with generalized myasthenia gravis (gMG) compared to other approved FcRn blockers. The findings were presented at the European Academy of Neurology (EAN) 2025 Congress in Helsinki, Finland. Gil C/ According to the findings, IMAAVY showed a comparable onset of symptom relief at Week 1. The drug demonstrated consistent and sustained disease control over multiple timepoints up to 24 weeks. More importantly, IMAAVY showed greater or statistically significant improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) scores compared to the published Phase 3 data of other FcRn blockers. The drug received FDA approval on April 30, 2025, for adults and pediatric patients aged 12 and older with anti-AChR or anti-MuSK antibody-positive gMG. This makes IMAAVY the first and only FcRn blocker approved for both antibody types, covering ≥90% of antibody-positive gMG patients. Johnson & Johnson (NYSE:JNJ) is a global healthcare company. It develops, manufactures, and sells pharmaceuticals and medical devices through two main segments: Innovative Medicine and MedTech. Its key pharmaceutical products include Darzalex, Stelara, Tremfya, and Carvykti, while its MedTech offerings span surgical technologies, orthopedics, and vision care. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
